Hydroxymethylglutaryl-CoA Reductase Inhibitors
"Hydroxymethylglutaryl-CoA Reductase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis.
MeSH Number(s)
D27.505.519.186.071.202.370
D27.505.519.389.370
D27.505.954.557.500.202.370
Concept/Terms
Hydroxymethylglutaryl-CoA Reductase Inhibitors- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Hydroxymethylglutaryl CoA Reductase Inhibitors
- Inhibitors, Hydroxymethylglutaryl-CoA Reductase
- Reductase Inhibitors, Hydroxymethylglutaryl-CoA
- Statins, HMG-CoA
- HMG-CoA Statins
- Statins, HMG CoA
- Inhibitors, Hydroxymethylglutaryl-CoA
- Hydroxymethylglutaryl-CoA Inhibitors
- Inhibitors, Hydroxymethylglutaryl CoA
- Inhibitors, Hydroxymethylglutaryl-Coenzyme A
- Hydroxymethylglutaryl-Coenzyme A Inhibitors
- Inhibitors, Hydroxymethylglutaryl Coenzyme A
- HMG-CoA Reductase Inhibitors
- HMG CoA Reductase Inhibitors
- Reductase Inhibitors, HMG-CoA
- Inhibitors, HMG-CoA Reductase
- Inhibitors, HMG CoA Reductase
Below are MeSH descriptors whose meaning is more general than "Hydroxymethylglutaryl-CoA Reductase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Hydroxymethylglutaryl-CoA Reductase Inhibitors".
This graph shows the total number of publications written about "Hydroxymethylglutaryl-CoA Reductase Inhibitors" by people in Harvard Catalyst Profiles by year, and whether "Hydroxymethylglutaryl-CoA Reductase Inhibitors" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 3 | 4 |
1995 | 0 | 1 | 1 |
1997 | 3 | 0 | 3 |
1998 | 7 | 1 | 8 |
1999 | 3 | 1 | 4 |
2000 | 13 | 6 | 19 |
2001 | 17 | 4 | 21 |
2002 | 29 | 3 | 32 |
2003 | 27 | 12 | 39 |
2004 | 31 | 6 | 37 |
2005 | 45 | 3 | 48 |
2006 | 45 | 23 | 68 |
2007 | 49 | 17 | 66 |
2008 | 38 | 24 | 62 |
2009 | 51 | 14 | 65 |
2010 | 51 | 18 | 69 |
2011 | 67 | 26 | 93 |
2012 | 66 | 20 | 86 |
2013 | 63 | 22 | 85 |
2014 | 77 | 20 | 97 |
2015 | 97 | 27 | 124 |
2016 | 60 | 35 | 95 |
2017 | 82 | 27 | 109 |
2018 | 74 | 26 | 100 |
2019 | 69 | 35 | 104 |
2020 | 73 | 36 | 109 |
2021 | 67 | 14 | 81 |
2022 | 97 | 4 | 101 |
2023 | 70 | 4 | 74 |
2024 | 13 | 0 | 13 |
Below are the most recent publications written about "Hydroxymethylglutaryl-CoA Reductase Inhibitors" by people in Profiles.
-
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial. JAMA Cardiol. 2024 Apr 01; 9(4):323-334.
-
Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial. Eur Heart J. 2024 Apr 01; 45(13):1173-1176.
-
Statin Twitter: Human and Automated Bot Contributions, 2010 to 2022. J Am Heart Assoc. 2024 Apr 02; 13(7):e032678.
-
Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral Microbleeds. Neurology. 2024 Apr 09; 102(7):e209173.
-
Bringing Evidence to the Nursing Home: Do Statins Have a Role for Prevention in Patients With and Without Dementia? Neurology. 2024 Mar 26; 102(6):e209262.
-
Statin use and mortality in patients with deep vein thrombosis. Data from the RIETE Registry. Thromb Res. 2024 Apr; 236:88-96.
-
Evaluating different low-density lipoprotein cholesterol thresholds to initiate statin for prevention of cardiovascular diseases in patients with type 2 diabetes mellitus: A target trial emulation study. Diabetes Obes Metab. 2024 May; 26(5):1877-1887.
-
N-Glycosylation Profiles of Immunoglobulin G and Future Cardiovascular Events. Circ Res. 2024 03; 134(5):e3-e14.
-
SLCO1B3 and SLCO2B1 genotypes, androgen deprivation therapy, and prostate cancer outcomes: a prospective cohort study and meta-analysis. Carcinogenesis. 2024 02 12; 45(1-2):35-44.
-
Icosapent ethyl for hypertriglyceridaemia and atherosclerosis: greater RESPECT for increased therapeutic use. Eur Heart J. 2024 Feb 07; 45(6):439-442.